資本剰余金、研究開発費
- 【期間】
| 年度 | 資本剰余金 | 研究開発費 |
|---|
| 2008/03 | 879億 | | - | |
| 2009/03 | 799億 | -9.2% | - | |
| 2010/03 | 800億 | +0.1% | - | |
| 2010/12 | 800億 | +0% | - | |
| 2011/03 | 699億 | -12.6% | - | |
| 2011/06 | 699億 | ±0% | - | |
| 2011/09 | 606億 | -13.3% | - | |
| 2011/12 | 606億 | ±0% | - | |
| 2012/03 | 522億 | -13.8% | - | |
| 2012/06 | 522億 | ±0% | - | |
| 2012/09 | 522億 | ±0% | - | |
| 2012/12 | 522億 | ±0% | - | |
| 2013/03 | 522億 | ±0% | 166億 | |
| 2013/06 | 522億 | ±0% | - | |
| 2013/09 | 522億 | ±0% | - | |
| 2013/12 | 522億 | ±0% | - | |
| 2014/03 | 522億 | ±0% | 164億 | -1.1% |
| 2014/06 | 522億 | ±0% | - | |
| 2014/09 | 522億 | ±0% | - | |
| 2014/12 | 522億 | +0% | - | |
| 2015/03 | 522億 | ±0% | 188億 | +14.1% |
| 2015/06 | 522億 | ±0% | - | |
| 2015/09 | 522億 | ±0% | - | |
| 2015/12 | 522億 | ±0% | - | |
| 2016/03 | 522億 | ±0% | 182億 | -3% |
| 2016/06 | 522億 | ±0% | - | |
| 2016/09 | 522億 | ±0% | - | |
| 2016/12 | 521億 | -0.3% | - | |
| 2017/03 | 521億 | ±0% | 178億 | -2.4% |
| 2017/06 | 521億 | ±0% | - | |
| 2017/09 | 522億 | +0.2% | - | |
| 2017/12 | 522億 | ±0% | - | |
| 2018/03 | 522億 | +0.1% | 194億 | +9.2% |
| 2018/06 | 522億 | ±0% | - | |
| 2018/09 | 523億 | +0.2% | - | |
| 2018/12 | 523億 | ±0% | - | |
| 2019/03 | 523億 | ±0% | 198億 | +2.1% |
| 2019/06 | 523億 | ±0% | - | |
| 2019/09 | 525億 | +0.3% | - | |
| 2019/12 | 527億 | +0.5% | - | |
| 2020/03 | 520億 | -1.4% | 190億 | -3.9% |
| 2020/06 | 520億 | ±0% | - | |
| 2020/09 | 522億 | +0.4% | - | |
| 2020/12 | 522億 | +0% | - | |
| 2021/03 | 522億 | +0% | 264億 | +38.9% |
| 2021/06 | 521億 | -0.2% | - | |
| 2021/09 | 524億 | +0.6% | - | |
| 2021/12 | 524億 | ±0% | - | |
| 2022/03 | 526億 | +0.3% | 295億 | +11.5% |
| 2022/06 | 526億 | ±0% | - | |
| 2022/09 | 529億 | +0.6% | - | |
| 2022/12 | 529億 | ±0% | - | |
| 2023/03 | 529億 | ±0% | 304億 | +2.9% |
| 2023/06 | 529億 | ±0% | - | |
| 2023/09 | 533億 | +0.8% | - | |
| 2023/12 | 533億 | ±0% | - | |
| 2024/03 | 533億 | ±0% | 323億 | +6.4% |
| 2024/06 | 434億 | -18.6% | - | |
